Home
Jones Day
Kevin D. McDonald
Kevin D. McDonald
Jones Day
Jury Finds For Drug Manufacturers In First Post-Actavis "Reverse Payment" Trial
15 Dec 2014 | United States
Split Federal Circuit Decision Revives Antitrust Counterclaims In Patent Litigation
18 Aug 2014 | United States
FTC Expands Premerger Notification Requirements To Cover Certain Pharmaceutical Patent Licenses
22 Nov 2013 | United States
Supreme Court Holds Reverse Payment Settlements Potentially Anticompetitive – Further Guidance Awaits
12 Jul 2013 | United States
Antitrust Alert: New FTC Pharma Patent Litigation Report Finds Increase In "Reverse Payment" Settlements Based On Expanded Definition Of "Payments"
12 Feb 2013 | United States
Second Circuit Decision On Pleading Conspiracy More Welcoming To Plaintiffs
11 Feb 2013 | United States
FTC Releases Report On Authorized Generic Drugs
28 Sep 2011 | United States
Pending U.S. Legislation to Ban "Reverse Payment" Settlements Would Bring Fundamental Change (and Uncertainty) to Drug Patent Litigation
15 Sep 2010 | United States
FTC Staff Report Criticizes Pharmaceutical Patent Settlements
03 Feb 2010 | United States
FTC "No Action" On Pharmaceutical Patent Settlements Does Not Spell End To Reverse Payments Dispute
07 Apr 2009 | United States
Antitrust Risks In Settling Patent Cases: The FTC And Congress Continue The Attack, While The Courts Continue To Be Unimpressed
10 Mar 2009 | United States
U.S. Court Of Appeals Upholds Validity Of "Reverse Payment" Patent Settlements
30 Oct 2008 | United States
Antitrust and the 2005 Supreme Court Term
03 Oct 2005 | United States
Contact Details
Washington, DC
Email Website
Washington, DC
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.